CATALOGO DEI PRODOTTI DELLA RICERCA

CALIÒ, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.209
NA - Nord America 2.008
AS - Asia 1.112
AF - Africa 27
SA - Sud America 12
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.377
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.003
GB - Regno Unito 731
CN - Cina 657
SG - Singapore 359
IT - Italia 300
SE - Svezia 250
RU - Federazione Russa 238
IE - Irlanda 214
FR - Francia 171
DE - Germania 133
FI - Finlandia 80
UA - Ucraina 37
BE - Belgio 23
TG - Togo 21
HK - Hong Kong 18
JP - Giappone 15
KR - Corea 15
VN - Vietnam 11
AU - Australia 7
BR - Brasile 6
TR - Turchia 6
ID - Indonesia 5
IR - Iran 5
NL - Olanda 5
CA - Canada 4
IN - India 4
PL - Polonia 4
AR - Argentina 3
AT - Austria 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
MA - Marocco 3
MK - Macedonia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CL - Cile 2
CM - Camerun 2
ES - Italia 2
HU - Ungheria 2
LV - Lettonia 2
PH - Filippine 2
AM - Armenia 1
BG - Bulgaria 1
CY - Cipro 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
ME - Montenegro 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 5.377
Salva come PNG Salva come JPEG
Città #
Southend 688
Chandler 416
Singapore 304
Dublin 212
Woodbridge 159
Jacksonville 148
Ann Arbor 138
Beijing 133
Ashburn 126
Lawrence 68
Princeton 68
Wilmington 67
Verona 61
Jinan 59
Houston 54
New York 51
Shenyang 46
Redmond 42
Helsinki 36
Hebei 34
Nanjing 33
Sindelfingen 31
Santa Clara 27
Tianjin 27
Ningbo 26
Bologna 24
Changsha 23
Milan 22
Redwood City 22
Seattle 22
Lomé 21
Hangzhou 19
Brussels 18
Lancaster 17
Taizhou 17
Zhengzhou 17
Rome 15
Nanchang 14
Seoul 14
Hong Kong 13
Taiyuan 13
Moscow 12
Dallas 11
Dearborn 11
Guangzhou 11
Munich 11
Tokyo 11
Fairfield 10
Haikou 10
Norwalk 10
Boardman 9
Pozza 9
Washington 8
Bergamo 7
Dong Ket 7
Falls Church 7
Fuzhou 7
Jiaxing 7
San Donà Di Piave 7
Kent 6
Boydton 5
Düsseldorf 5
Lappeenranta 5
Los Angeles 5
San Francisco 5
Amsterdam 4
Augusta 4
Berlin 4
Cagliari 4
Chicago 4
Jakarta 4
Lozzo Atestino 4
Paese 4
Perugia 4
Ardabil 3
Brno 3
Buenos Aires 3
Cambridge 3
Detroit 3
Hefei 3
Isola della Scala 3
Lanzhou 3
Lonigo 3
Nuremberg 3
Phoenix 3
Prilep 3
Rio Saliceto 3
Romola 3
Shanghai 3
Shenzhen 3
Toronto 3
Vienna 3
Auburn Hills 2
Baku 2
Bonate Sotto 2
Cementon 2
Dongguan 2
Durham 2
Fremont 2
Genova 2
Totale 3.647
Salva come PNG Salva come JPEG
Nome #
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 153
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 131
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis 129
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 125
Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. 124
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 121
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 119
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 116
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 111
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 110
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 109
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 109
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 103
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 102
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 97
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 97
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 97
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 96
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 92
Increased Frequency of Bronchiolar Histotypes in Lung Carcinomas Associated with Idiopathic Pulmonary Fibrosis 88
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 88
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 86
Primary Seminal Vesicle Carcinoma. The Usefulness of Pax8 Immunohistochemical Expression for the Differential Diagnosis 84
Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases 81
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 79
Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung 78
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 75
MiT family translocation renal cell carcinoma: looking for diagnostic and druggable markers 72
Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer? 68
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma 67
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 67
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 66
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 65
Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review 64
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 62
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'? 61
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment 61
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 61
From fine-needle aspiration cytology to fluorescent in-situ hybridization in an unusual case of pharyngeal synovial sarcoma 60
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys 60
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 60
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 60
Renomedullary Interstitial Cell Tumors: Pathologic Features and Clinical Correlations 59
Histology and immunohistochemical evaluation of phimotic prepuce: The role of steroid therapy 58
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens 57
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss 55
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 53
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 52
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour 52
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 52
Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai 51
Recurrent primary endobronchial fetal rhabdomyoma: a case report and literature review 51
Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation 50
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 50
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 50
Intestinal-type primary vaginal adenocarcinoma. Review of the literature with report of a case: from diagnosis to management 49
Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases 48
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification 47
Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press 46
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 46
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey 45
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 43
Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. 42
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 42
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 40
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas 40
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 36
Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study 35
Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3 34
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 34
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 33
2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis 31
Hot topics in renal cancer pathology: implications for clinical management 30
Multitarget Fluorescence in Situ Hybridization diagnostic applications in solid and hematological tumors 29
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) 28
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 27
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 24
HER2 Aberrations in NSCLC: So Close Yet So Far 23
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers 20
Robot-assisted excision of hemangioma of the right renal vein 20
WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist 19
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 18
Histology for nephrology, from pre-implantation to post-transplant kidney biopsy. Lesson learned from ReBIrth (Renal BIopsy for Kidney Transplantation Therapy) 17
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 17
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 17
The World Health Organization 2022 Classification of renal tumors: key updates for urologists 16
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 16
MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management 16
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 15
Small renal masses in young adults: Insights from a large contemporary multi-institutional Registry 15
Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior 13
Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature 13
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 12
TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum 11
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations 11
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 10
Oncocytoma on renal mass biopsy: why is surgery even performed? 10
SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP) 10
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe 9
Metastatic de-novo renal cell carcinoma in the era of immune combinations: what can we learn from real-world data? 8
Totale 5.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.777
article - articoli 22.045
book - libri 0
conference - conferenze 523
curatela - curatele 0
other - altro 209
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020346 0 0 0 0 56 73 38 21 32 40 34 52
2020/2021604 69 68 34 81 73 79 29 19 18 31 67 36
2021/2022598 65 151 3 69 29 26 17 37 20 14 42 125
2022/20231.260 80 134 105 220 99 330 19 65 130 21 33 24
2023/2024786 35 55 73 73 88 127 42 54 22 48 122 47
2024/2025849 124 136 185 319 85 0 0 0 0 0 0 0
Totale 5.628